NPPA Announces New Drug Price Regulation 2025

The National Pharmaceutical Pricing Authority (NPPA) has issued a new order under the Drugs (Prices Control) Order, 2013, fixing retail prices for certain new drug formulations. Manufacturers are directed to set retail prices as mentioned in the official table and may add GST only if it is actually payable to the government.

As per DPCO provisions, manufacturers must issue a price list in Form V and submit it through IPDMS, along with copies to the State Drug Controller and dealers. Retailers and dealers are required to display the approved price list and any supplementary lists prominently at their business premises.

The fixed retail price applies only to manufacturers or marketers who have obtained approval through Form I and hold valid manufacturing licenses. Any violation or overcharging will require repayment with interest under DPCO 2013 and the Essential Commodities Act, 1955. Earlier price orders for the same formulations stand superseded following this notification.